Latest Issues

view more
March 2026 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

March 2026 - Pharmaceutical Market Europe

Inside this issue: Exploring the UK’s advanced therapy pipeline, closing the hormone gap in women's health, and tackling medicines access delays, plus features on building US media trust for European biotechs and the future of pharma manufacturing.

February 2026 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

February 2026 - Pharmaceutical Market Europe

Special feature on GenAI and its impact on pharma – A focus on Rare Disease Day on 28 February – Top Five Most Studied Diseases report

January  2026 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

January 2026 - Pharmaceutical Market Europe

Expert articles on alzheimer's disease & dementia, clinical trial barriers, early diagnosis in Europe, plus ASH 2025 hematology conference coverage and oral health links to autoimmune disease.

December 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

December 2025 - Pharmaceutical Market Europe

Thermo Fisher Scientific’s Martin Danielson talks to PME; Celebrating the 2025 PMEAs; Redefining the prostate cancer landscape

November 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

November 2025 - Pharmaceutical Market Europe

ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing impact on supply chains

October 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

October 2025 - Pharmaceutical Market Europe

Explore the 'Patient Metro' journey, the pillars of Alzheimer's blood testing, and how to de-risk clinical trials with platelet analysis for improved healthcare outcomes.

September 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

September 2025 - Pharmaceutical Market Europe

Will data and AI transform launch excellence? The impact of us tariffs on healthcare and life sciences; The power of digital and AI engineering

July/August 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

July/August 2025 - Pharmaceutical Market Europe

Full coverage of this year’s Communiqué Awards; The importance of patient engagement; Cannes Lions 2025 highlights

June 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

June 2025 - Pharmaceutical Market Europe

Communicating with HCPs through AI; ASCO 2025 highlights; The impact of US tariffs on pharma manufacturing

May 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

May 2025 - Pharmaceutical Market Europe

Rising to meet the challenges of clinical trials; Accelerating access to rare disease treatments; Maximising the potential of AI in pharma

April 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

April 2025 - Pharmaceutical Market Europe

How HCPs and patients are partnering to transform care; The impact of MS on ageing patients; AI in healthcare

March 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

March 2025 - Pharmaceutical Market Europe

PMLiVE’s Top Pharma List is live!; Omnichannel – breaking down the barriers; Rare diseases – improving patient access

February 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

February 2025 - Pharmaceutical Market Europe

Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in clinical trials

January 2025 - Pharmaceutical Market Europe
Pharmaceutical Market Europe

January 2025 - Pharmaceutical Market Europe

Avalere Health’s Amar Urhekar on his career path; Insights from ASH 2024; The science behind gene-silencing technology

Thought Leadership

view more
article-category

31 THOUGHT LEADER 9 Labs

Picking your omnichannel direction requires a disciplined, scientific approach

Thought Leadership, 26 March 2026
article-category

27 THOUGHT LEADER Anthill

Thought Leadership, 26 March 2026
article-category

27 AI-enabled, human-interpreted: the future of pharma marketing insights is precision intelligence

Thought Leadership, 24 February 2026
article-category

32 GenAI in healthcare: why privacy and literacy matter more than the tech

Thought Leadership, 24 February 2026
article-category

31 Pandemic readiness is now a financial risk test – and the UK must treat it that way

Thought Leadership, 24 February 2026
article-category

28-30 The race to explore and harness GenAI in healthcare

Thought Leadership, 24 February 2026

News & Columns

view more
article-category

9 News

article-category

10 NEWS

article-category

6 News

Roche and Ascidian agree to $1.8bn neurological disease partnership

article-category

12 Brian D Smith Darwin’s MEDICINE Corporate mayflies vs bowhead whales

How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?

article-category

7 News

article-category

13 Mike Dixon WE'RE ALL IN THIS TOGETHER

article-category

8 News

Researchers identify new major cause of inflammatory bowel disease

article-category

11 DERMATOLOGY NEWS

article-category

14 MAXINE SMITH AND GARETH HALL LEADING THROUGH OVERWHELM IN PHARMA AND BIOTECH LAUNCHES

article-category

15 NEIL FLASH - DOES PHARMA HAVE A PROGRESS PROBLEM?

article-category

9 News

article-category

10 DERMATOLOGY NEWS

article-category

14 MAXINE SMITH AND SIMON CAMPLING

article-category

8 News

Researchers identify new major cause of inflammatory bowel disease

article-category

13 Mike Dixon With LIFELINE

article-category

7 News

Features

view more
article-category

22-23 WOMEN’S HEALTH

Features, 26 March 2026
article-category

18-19 PHARMA MARKET ACCESS

CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value

Features, 26 March 2026
article-category

16-17 CLINICAL TRIALS AND GENE THERAPY

Across almost every sector, brands are multiplying their investment in creativity

Features, 26 March 2026
article-category

24-25 EUROPEAN AND US BIOTECH

Features, 26 March 2026
article-category

25 GenAI in healthcare – friend or foe?

Features, 24 February 2026
article-category

18-19 Patient-centricity in rare disease: accelerating the path to treatment

CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value

Features, 24 February 2026

Communiqué - Marketing & Comms

view more
article-category

28-30 COMMS EXCELLENCE

Communique - Marketing & Comms, 26 March 2026
article-category

34-35 PHARMA MANUFACTURING

Communique - Marketing & Comms, 26 March 2026
article-category

32-33 CANCER GRAND CHALLENGES

Communique - Marketing & Comms, 26 March 2026
article-category

39 Cuttsy+Cuttsy becomes employee-owned

Communique - Marketing & Comms, 23 February 2026
article-category

26-31 PMEA 2025: a celebration of excellence in pharmaceutical marketing

Communique - Marketing & Comms, 18 December 2025
article-category

32 TL JPA HEALTH - Clicks vs credibility: how social media underscores patient understanding

Communique - Marketing & Comms, 18 December 2025

Careers & Recruitment

view more
article-category

38 Appointments

Appointments & Recruitment, 26 March 2026
article-category

36 Appointments

Appointments & Recruitment, 26 March 2026
article-category

37 Appointments

Appointments & Recruitment, 26 March 2026
article-category

41 Appointments

Appointments & Recruitment, 24 February 2026
article-category

40 Appointments

Appointments & Recruitment, 24 February 2026
article-category

42 Appointments

Appointments & Recruitment, 23 February 2026

PME Supplements

view more
DIVERSITY, EQUITY AND INCLUSION - PME Supplement March 2022

DIVERSITY, EQUITY AND INCLUSION - PME Supplement March 2022

DIVERSITY, EQUITY AND INCLUSION - A diverse, equitable and inclusive organisation performs better as it can engage with diverse communities, and catalyse greater creativity and innovation

Amarin - October 2021 PME Supplement

Amarin - October 2021 PME Supplement

Amarin Supplement with October 2021 PME Amarin in Europe - Rethinking Cardiovascular Risk, Transforming the CVD Treatment Paradigm in Europe, Delivering Launch Excellence Across Europe, Pharma Marketing Challenges During a Pandemic

How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020

How AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020

As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate. This supplement looks at how these innovations can help HCPs in the fight against COVID-19.

DIGITAL, DOCTORS AND PATIENTS - PME Supplement March 2020

DIGITAL, DOCTORS AND PATIENTS - PME Supplement March 2020

DIGITAL, DOCTORS AND PATIENTS - Key emerging trends in digital health. Current and future trends for developing digital medical communications: Evolving digital trends and user needs. Key emerging trends in digital health: Improving healthcare for patients and helping doctors to be more efficient

PATIENT ENGAGEMENT - PME Supplement - September 2019

PATIENT ENGAGEMENT - PME Supplement - September 2019

PATIENT ENGAGEMENT - PME September 2019 Supplement - The business case for patient engagement: using digital to bridge the engagement gap between patients and pharma. Understanding the patient journey: what can we learn from customer service. How technology is driving new trends in patient engagement.

How to Install